EUnetHTA is conducting a pilot by WP5

EUnetHTA is conducting a pilot by WP5, Relative Effectiveness Assessment (REA) of Pharmaceuticals, in which the draft tools that are being developed for relative effectiveness assessment of pharmaceuticals are tested. The first draft version of the report (rapid assessment of pazopanib for the treatment of advanced renal cell cancer) was ready in November 2011 and […]